Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Ixifi
Australian Public Assessment Report
Device/Product Name
Ixifi
Active ingredients
Infliximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2023-04183-1-3
Submission Type
New biosimilar
Decision
Approved